Back

ENSURE-AF study: Edoxaban for cardioversion of atrial fibrillation

30 August 2016 (14:00 - 14:10)
Organised by:
Congress Presentation Part of: Hot Line preventive strategies 2 Electrocardiography ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Andreas Goette

Saint Vincenz Hospital Paderborn, Paderborn (Germany)

11 More presentations in this session

Presentation thumbnail
ENSURE-AF - Discussant review
Doctor R. Cappato (Sesto San Giovanni, IT)
Slides Video
Presentation thumbnail
ENSURE-AF - Panel discussion
Video
Presentation thumbnail
ANNEXA-4 - Andexanet alfa for reversal of Factor Xa inhibitors in patients with acute major bleeding
Doctor S. Connolly (Hamilton, CA)
Slides Video
Presentation thumbnail
ANNEXA-4 - Discussant review
Professor G. Lip (Liverpool, GB)
Presentation thumbnail
ANNEXA-4 - Panel discussion
Video

Access the full session

Session thumbnail
Hot Line preventive strategies 2

The Event

Event poster

ESC Congress 2016

30 August 2016 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Left atrial thrombus in heart failure patients undergoing elective electrical cardioversion despite guideline-recommended anticoagulation: prevalence, predictors and prognosis
12 April 2026
thumbnail
Congress Presentation
Low-dose edoxaban in patients 80 years and older with atrial fibrillation and dose-reduction criteria: randomized analysis between edoxaban 15 mg and 30 mg
1 September 2025
thumbnail
Congress Presentation
1 September 2019
thumbnail
Congress Presentation
Balancing stroke and bleeding risks: the impact of stopping anticoagulation after aAF ablation - a systematic review and meta-analysis
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources